Shulan Han

1.2k total citations · 1 hit paper
18 papers, 885 citations indexed

About

Shulan Han is a scholar working on Immunology, Oncology and Biomedical Engineering. According to data from OpenAlex, Shulan Han has authored 18 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Shulan Han's work include Immune cells in cancer (6 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Shulan Han is often cited by papers focused on Immune cells in cancer (6 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Shulan Han collaborates with scholars based in China, Ireland and United States. Shulan Han's co-authors include Jianfeng Guo, Yifang Zou, Zhuo Yu, Huimei Wang, Shengfang Wang, Lianyan Wang, Tingyuan Yang, Yun Dai, Rui-Jun Ju and Dandan Sun and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and Nanoscale.

In The Last Decade

Shulan Han

18 papers receiving 877 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma

2023 178 citations Shulan Han, Xueying Bao et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shulan Han China	13	360	338	247	167	152	18	885
Meiqun Cao China	13	119 0.3×	332 1.0×	268 1.1×	198 1.2×	115 0.8×	23	900
Qihui Huang China	15	273 0.8×	350 1.0×	105 0.4×	82 0.5×	323 2.1×	40	1.2k
Yuping Liu China	20	151 0.4×	507 1.5×	108 0.4×	89 0.5×	149 1.0×	55	1.1k
Hassan Dariushnejad Iran	17	135 0.4×	453 1.3×	72 0.3×	123 0.7×	126 0.8×	47	908
Gamze Güney Eskiler Türkiye	20	87 0.2×	445 1.3×	161 0.7×	183 1.1×	220 1.4×	92	984
Meng Lan China	12	150 0.4×	210 0.6×	93 0.4×	81 0.5×	173 1.1×	14	541
Xiaomeng Tang China	18	108 0.3×	392 1.2×	182 0.7×	196 1.2×	90 0.6×	38	945
Ying Luo China	17	317 0.9×	212 0.6×	69 0.3×	87 0.5×	87 0.6×	75	901
Davoud Jafari-Gharabaghlou Iran	17	59 0.2×	355 1.1×	152 0.6×	204 1.2×	122 0.8×	42	871
Yutong Li China	15	122 0.3×	459 1.4×	113 0.5×	44 0.3×	75 0.5×	60	830

Countries citing papers authored by Shulan Han

Since Specialization

Citations

This map shows the geographic impact of Shulan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shulan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shulan Han more than expected).

Fields of papers citing papers by Shulan Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shulan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shulan Han. The network helps show where Shulan Han may publish in the future.

Co-authorship network of co-authors of Shulan Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shulan Han. A scholar is included among the top collaborators of Shulan Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shulan Han. Shulan Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wang, Limei, Li Xu, Feng Li, et al.. (2024). Nano delivery of juglone causes cell cycle arrest and apoptosis for hepatocellular carcinoma therapy. Journal of Drug Delivery Science and Technology. 93. 105431–105431. 2 indexed citations

Cao, Chenyu, Yifei Li, Shanshan Jiang, et al.. (2024). Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma. International Journal of Pharmaceutics. 661. 124424–124424. 12 indexed citations

Gao, Yuan, Shulan Han, Qi Liu, et al.. (2024). Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nanoadjuvant Enhances the Immunity and Cross-Protection of an NM2e-Based Universal Influenza Vaccine. ACS Nano. 18(20). 12905–12916. 5 indexed citations

Li, Yanan, Xiaoju Shi, Dandan Sun, et al.. (2023). Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma. International Journal of Pharmaceutics. 636. 122791–122791. 14 indexed citations

Han, Shulan, Xueying Bao, Yifang Zou, et al.. (2023). d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Science Advances. 9(29). eadg2697–eadg2697. 178 indexed citations breakdown →

Yu, Zhuo, Yifang Zou, Shulan Han, et al.. (2023). Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity. Fundamental Research. 5(3). 1298–1312. 6 indexed citations

Han, Shulan, et al.. (2023). Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles. Journal of Functional Biomaterials. 14(3). 136–136. 12 indexed citations

Li, Linlin, Yifang Zou, Lingzhi Wang, et al.. (2023). Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma. International Journal of Pharmaceutics. 642. 123114–123114. 18 indexed citations

Han, Shulan, Tingting Guo, Dandan Sun, et al.. (2022). Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer. Journal of Controlled Release. 348. 250–263. 66 indexed citations

10.

Yun, Cholil, Yutong Shi, Yuan Gao, et al.. (2022). Enhancement of flavonoid synthesis and antioxidant activity in Scutellaria baicalensis aerial parts by UV-A radiation. Industrial Crops and Products. 187. 115532–115532. 12 indexed citations

11.

Yun, Cholil, Shulan Han, Yutong Shi, et al.. (2022). Postharvest UV-A radiation affects flavonoid content, composition, and bioactivity of Scutellaria baicalensis root. Postharvest Biology and Technology. 189. 111933–111933. 24 indexed citations

12.

Sun, Dandan, Yifang Zou, Song Liu, et al.. (2021). A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharmaceutica Sinica B. 12(1). 378–393. 152 indexed citations

13.

Gao, Yuan, Shengfang Wang, Shulan Han, et al.. (2021). Optimized ultrasound-assisted extraction of total polyphenols from Empetrum nigrum and its bioactivities. Journal of Chromatography B. 1173. 122699–122699. 31 indexed citations

14.

Han, Shulan, Shengfang Wang, Tingyuan Yang, et al.. (2021). Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Theranostics. 11(6). 2892–2916. 192 indexed citations

15.

Han, Shulan, Wenyan Ma, Dawei Jiang, et al.. (2021). Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine. Journal of Nanobiotechnology. 19(1). 394–394. 31 indexed citations

16.

Zou, Yifang, Fang Xiao, Song Liu, et al.. (2021). A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer. International Journal of Pharmaceutics. 606. 120888–120888. 51 indexed citations

17.

Han, Shulan, Wenjie Wang, Shengfang Wang, et al.. (2019). Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages. Nanoscale. 11(42). 20206–20220. 68 indexed citations

18.

Wang, Huimei, Shulan Han, Lianyan Wang, et al.. (2017). Dual-function baicalin and baicalin-loaded poly(lactic-co-glycolic acid) nanoparticles: Immune activation of dendritic cells and arrest of the melanoma cell cycle at the G2/M phase. Particuology. 37. 64–71. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact